296 related articles for article (PubMed ID: 15566940)
1. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
Falke D; Fisher MH; Juliano RL
Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
[TBL] [Abstract][Full Text] [Related]
2. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene.
Falke D; Fisher M; Ye D; Juliano RL
Nucleic Acids Res; 2003 Feb; 31(3):e10. PubMed ID: 12560513
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
4. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
6. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.
Thornborrow EC; Manfredi JJ
J Biol Chem; 2001 May; 276(19):15598-608. PubMed ID: 11278953
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
[TBL] [Abstract][Full Text] [Related]
9. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
11. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
[TBL] [Abstract][Full Text] [Related]
12. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
13. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors.
Unezaki S; Nishizawa M; Okuda-Ashitaka E; Masu Y; Mukai M; Kobayashi S; Sawamoto K; Okano H; Ito S
Gene; 2004 Jul; 336(1):47-58. PubMed ID: 15225875
[TBL] [Abstract][Full Text] [Related]
15. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.
Sugars KL; Budhram-Mahadeo V; Packham G; Latchman DS
Nucleic Acids Res; 2001 Nov; 29(22):4530-40. PubMed ID: 11713302
[TBL] [Abstract][Full Text] [Related]
16. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).
Budram-Mahadeo V; Morris PJ; Latchman DS
Oncogene; 2002 Sep; 21(39):6123-31. PubMed ID: 12203124
[TBL] [Abstract][Full Text] [Related]
17. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
[TBL] [Abstract][Full Text] [Related]
19. Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21.
Yin Y; Zhu A; Jin YJ; Liu YX; Zhang X; Hopkins KM; Lieberman HB
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8864-9. PubMed ID: 15184659
[TBL] [Abstract][Full Text] [Related]
20. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]